Skip to main content
Erschienen in:

19.03.2019 | Review Article

Essentials for Pathological Evaluation of Peritoneal Surface Malignancies and Synoptic Reporting of Cytoreductive Surgery Specimens—A review and evidence-based guide

verfasst von: Aditi Bhatt, Suniti Mishra, Loma Parikh, Sandeep Sheth, Imran Gorur

Erschienen in: Indian Journal of Surgical Oncology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Peritoneal surface oncology has emerged as a subspecialty of surgical oncology, with the growing popularity of surgical treatment of peritoneal metastases comprising of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Pathological evaluation plays a key role in multidisciplinary management but there are still many areas where there are no guidelines or consensus on reporting. Some tumors presenting to a peritoneal surface oncology unit are rare and pathologists my not be familiar with diagnosing and classifying those. In this manuscript, we have reviewed the evidence regarding various aspects of histopathological evaluation of peritoneal tumors. It includes establishing a diagnosis, appropriate classification and staging of common and rare tumors and evaluation of pathological response to chemotherapy. In many instances, the information captured is of prognostic value alone with no direct therapeutic implications. But proper capturing of such information is vital for generating evidence that will guide future treatment trends and research. There are no guidelines/data set for reporting cytoreductive surgery specimens. Based on the authors’ experience, a format for handling/grossing and synoptic reporting of these specimens is provided.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Passot G, Vaudoyer D, Villeneuve L et al (2016) What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: a 25-year experience with 1,125 procedures. J Surg Oncol 113:796–803PubMedCrossRef Passot G, Vaudoyer D, Villeneuve L et al (2016) What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: a 25-year experience with 1,125 procedures. J Surg Oncol 113:796–803PubMedCrossRef
3.
Zurück zum Zitat Bhatt A, Mehta SS, Zaveri S, Rajan F, Ray M, Sethna K, Katdare N, Patel MD, Kammar P, Prabhu R, Sinukumar S, Mishra S, Rangarajan B, Rangole A, Damodaran D, Penumadu P, Ganesh M, Peedicayil A, Raj H, Seshadri R (2018) Treading the beaten path with old and new obstacles: a report from the Indian HIPEC registry. Int J Hyperth. https://doi.org/10.1080/02656736.2018.1503345 PubMedCrossRef Bhatt A, Mehta SS, Zaveri S, Rajan F, Ray M, Sethna K, Katdare N, Patel MD, Kammar P, Prabhu R, Sinukumar S, Mishra S, Rangarajan B, Rangole A, Damodaran D, Penumadu P, Ganesh M, Peedicayil A, Raj H, Seshadri R (2018) Treading the beaten path with old and new obstacles: a report from the Indian HIPEC registry. Int J Hyperth. https://​doi.​org/​10.​1080/​02656736.​2018.​1503345 PubMedCrossRef
5.
Zurück zum Zitat Neumeister VM, Anagnostou V, Siddiqui S et al (2012) Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues. J Natl Cancer Inst 104:1815–1824PubMedPubMedCentralCrossRef Neumeister VM, Anagnostou V, Siddiqui S et al (2012) Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues. J Natl Cancer Inst 104:1815–1824PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Portier BP, Wang Z, Downs-Kelly E et al (2013) Delay to formalin fixation ‘cold ischemia time’: effect on ERBB2 detection by in-situ hybridization and immunohistochemistry. Mod Pathol 26:1–9PubMedCrossRef Portier BP, Wang Z, Downs-Kelly E et al (2013) Delay to formalin fixation ‘cold ischemia time’: effect on ERBB2 detection by in-situ hybridization and immunohistochemistry. Mod Pathol 26:1–9PubMedCrossRef
7.
Zurück zum Zitat Engel KB, Moore HM (2011) Effects of pre-analytical variables on the detection of proteins by immunohistochemistry in formalin-fixed, paraffin-embedded tissue. Arch Pathol Lab Med 135:537–543PubMed Engel KB, Moore HM (2011) Effects of pre-analytical variables on the detection of proteins by immunohistochemistry in formalin-fixed, paraffin-embedded tissue. Arch Pathol Lab Med 135:537–543PubMed
8.
Zurück zum Zitat Arber DA (2002) Effect of prolonged formalin fixation on the immunohistochemical reactivity of breast markers. Appl Immunohistochem Mol Morphol 10:183–186PubMed Arber DA (2002) Effect of prolonged formalin fixation on the immunohistochemical reactivity of breast markers. Appl Immunohistochem Mol Morphol 10:183–186PubMed
9.
Zurück zum Zitat Babic A, Loftin IR, Stanislaw S et al (2010) The impact of pre-analytical processing on staining quality for H&E, dual hapten, dual color in situ hybridization and fluorescent in situ hybridization assays. Methods 52:287–300PubMedCrossRef Babic A, Loftin IR, Stanislaw S et al (2010) The impact of pre-analytical processing on staining quality for H&E, dual hapten, dual color in situ hybridization and fluorescent in situ hybridization assays. Methods 52:287–300PubMedCrossRef
11.
Zurück zum Zitat Kerr KM, Bubendorf L, Edelman MJ et al (2014) Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer. Ann Oncol 25:1681–1690PubMedCrossRef Kerr KM, Bubendorf L, Edelman MJ et al (2014) Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer. Ann Oncol 25:1681–1690PubMedCrossRef
12.
Zurück zum Zitat McCluggage WG, Judge MJ, Clarke BA, Davidson B, Gilks CB, Hollema H, Ledermann JA, Matias-Guiu X, Mikami Y, Stewart CJ, Vang R, Hirschowitz L (2015) International collaboration on cancer reporting. Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Mod Pathol 28(8):1101–1122. https://doi.org/10.1038/modpathol.2015.77 CrossRefPubMed McCluggage WG, Judge MJ, Clarke BA, Davidson B, Gilks CB, Hollema H, Ledermann JA, Matias-Guiu X, Mikami Y, Stewart CJ, Vang R, Hirschowitz L (2015) International collaboration on cancer reporting. Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Mod Pathol 28(8):1101–1122. https://​doi.​org/​10.​1038/​modpathol.​2015.​77 CrossRefPubMed
13.
Zurück zum Zitat Doig T, Monaghan H (2006) Sampling the omentum in ovarian neoplasia: when one block is enough. Int J Gynecol Cancer 16:36–40PubMedCrossRef Doig T, Monaghan H (2006) Sampling the omentum in ovarian neoplasia: when one block is enough. Int J Gynecol Cancer 16:36–40PubMedCrossRef
14.
Zurück zum Zitat Usubütün A, Ozseker HS, Himmetoglu C et al (2007) Omentectomy for gynecologic cancer: how much sampling is adequate for microscopic examination? Arch Pathol Lab Med 131:1578–1581PubMed Usubütün A, Ozseker HS, Himmetoglu C et al (2007) Omentectomy for gynecologic cancer: how much sampling is adequate for microscopic examination? Arch Pathol Lab Med 131:1578–1581PubMed
15.
Zurück zum Zitat Cotte E, Peyrat P, Piaton E, Chapuis F, Rivoire M, Glehen O, Arvieux C, Mabrut JY, Chipponi J, Gilly FN, EVOCAPE group (2013) Lack of prognostic significance of conventional peritoneal cytology in colorectal and gastric cancers: results of EVOCAPE 2 multicentre prospective study. Eur J Surg Oncol 39(7):707–714. https://doi.org/10.1016/j.ejso.2013.03.021 CrossRefPubMed Cotte E, Peyrat P, Piaton E, Chapuis F, Rivoire M, Glehen O, Arvieux C, Mabrut JY, Chipponi J, Gilly FN, EVOCAPE group (2013) Lack of prognostic significance of conventional peritoneal cytology in colorectal and gastric cancers: results of EVOCAPE 2 multicentre prospective study. Eur J Surg Oncol 39(7):707–714. https://​doi.​org/​10.​1016/​j.​ejso.​2013.​03.​021 CrossRefPubMed
16.
17.
Zurück zum Zitat Pande R, Sunga A, Levea C, Wilding GE, Bshara W, Reid M, Fakih MG (2008) Significance of signet-ring cells in patients with colorectal cancer. Dis Colon Rectum 51:50–55PubMedCrossRef Pande R, Sunga A, Levea C, Wilding GE, Bshara W, Reid M, Fakih MG (2008) Significance of signet-ring cells in patients with colorectal cancer. Dis Colon Rectum 51:50–55PubMedCrossRef
18.
Zurück zum Zitat Solass W, Sempoux C, Carr NJ, Detlefsen S, Bibeau F (2016) Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the Peritoneal Regression Grading Score (PRGS). Pleura Perit 1:99–107 Solass W, Sempoux C, Carr NJ, Detlefsen S, Bibeau F (2016) Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the Peritoneal Regression Grading Score (PRGS). Pleura Perit 1:99–107
19.
Zurück zum Zitat Bibeau F, Gil H, Castan F et al (2013) Comment on “Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab”. Br J Cancer 109:3127–3129PubMedPubMedCentralCrossRef Bibeau F, Gil H, Castan F et al (2013) Comment on Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab. Br J Cancer 109:3127–3129PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Chang HHL, Leeper WR, Chan G, Quan D, Driman DK (2012) Infarct-like necrosis: a distinct form of necrosis seen in colorectal carcinoma liver metastases treated with perioperative chemotherapy. Am J Surg Pathol 36:570–576PubMedCrossRef Chang HHL, Leeper WR, Chan G, Quan D, Driman DK (2012) Infarct-like necrosis: a distinct form of necrosis seen in colorectal carcinoma liver metastases treated with perioperative chemotherapy. Am J Surg Pathol 36:570–576PubMedCrossRef
21.
Zurück zum Zitat Becker K, Mueller JD, Schulmacher C, Ott K, Fink U, Busch R et al (2003) Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer 98:1521–1530PubMedCrossRef Becker K, Mueller JD, Schulmacher C, Ott K, Fink U, Busch R et al (2003) Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer 98:1521–1530PubMedCrossRef
22.
Zurück zum Zitat Chirieac LR, Swisher SG, Correa AM et al (2005) Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma. Clin Cancer Res 11:2229–2236PubMedCrossRef Chirieac LR, Swisher SG, Correa AM et al (2005) Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma. Clin Cancer Res 11:2229–2236PubMedCrossRef
23.
Zurück zum Zitat Shia J, McManus M, Guillem JG et al (2011) Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy. Am J Surg Pathol 35:127–134PubMedCrossRef Shia J, McManus M, Guillem JG et al (2011) Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy. Am J Surg Pathol 35:127–134PubMedCrossRef
24.
Zurück zum Zitat Lim S-B, Hong S-M, Yu CS et al (2013) Prevalence and clinical significance of acellular mucin in locally advanced rectal cancer patients showing pathologic complete response to preoperative chemoradiotherapy. Am J Surg Pathol 37:47–52PubMedCrossRef Lim S-B, Hong S-M, Yu CS et al (2013) Prevalence and clinical significance of acellular mucin in locally advanced rectal cancer patients showing pathologic complete response to preoperative chemoradiotherapy. Am J Surg Pathol 37:47–52PubMedCrossRef
25.
Zurück zum Zitat Passot G, You B, Boschetti G, Fontaine J, Isaac S, Decullier E, Maurice C, Vaudoyer D, Gilly FN, Cotte E, Glehen O (2014) Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis. Ann Surg Oncol 21(8):2608–2614. https://doi.org/10.1245/s10434-014-3647-0 CrossRefPubMed Passot G, You B, Boschetti G, Fontaine J, Isaac S, Decullier E, Maurice C, Vaudoyer D, Gilly FN, Cotte E, Glehen O (2014) Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis. Ann Surg Oncol 21(8):2608–2614. https://​doi.​org/​10.​1245/​s10434-014-3647-0 CrossRefPubMed
26.
Zurück zum Zitat Rubbia-Brandt L et al (2007) Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol 18(2):299–304PubMedCrossRef Rubbia-Brandt L et al (2007) Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol 18(2):299–304PubMedCrossRef
27.
Zurück zum Zitat Blazer DG 3rd et al (2008) Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol 26(33):5344–5351PubMedCrossRef Blazer DG 3rd et al (2008) Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol 26(33):5344–5351PubMedCrossRef
30.
Zurück zum Zitat McCluggage WG, Wilkinson N (2005) Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features. Histopathology 47:231–247PubMedCrossRef McCluggage WG, Wilkinson N (2005) Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features. Histopathology 47:231–247PubMedCrossRef
32.
Zurück zum Zitat McCluggage WG (2002) Recent advances in immunohistochemistry in gynaecological pathology. Histopathology 46:309–326CrossRef McCluggage WG (2002) Recent advances in immunohistochemistry in gynaecological pathology. Histopathology 46:309–326CrossRef
33.
Zurück zum Zitat McCluggage WG, Young RH (2005) Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors. Semin Diagn Pathol 22:3–32PubMedCrossRef McCluggage WG, Young RH (2005) Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors. Semin Diagn Pathol 22:3–32PubMedCrossRef
34.
Zurück zum Zitat Vang R, Gown AM, Barry TS et al (2006) Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases. Am J Surg Pathol 30:1130–1139PubMedCrossRef Vang R, Gown AM, Barry TS et al (2006) Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases. Am J Surg Pathol 30:1130–1139PubMedCrossRef
35.
Zurück zum Zitat Strickland S, Parra-Herran C (2016) Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary mucinous tumours. Histopathology 68:977–987PubMedCrossRef Strickland S, Parra-Herran C (2016) Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary mucinous tumours. Histopathology 68:977–987PubMedCrossRef
36.
Zurück zum Zitat Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT (2016) SATB expression distinguishes ovarian metastases of colorectal and appendiceal origin from primary ovarian tumors of mucinous or endometrioid type. Am J Surg Pathol 40:419–432PubMedCrossRef Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT (2016) SATB expression distinguishes ovarian metastases of colorectal and appendiceal origin from primary ovarian tumors of mucinous or endometrioid type. Am J Surg Pathol 40:419–432PubMedCrossRef
37.
Zurück zum Zitat Leen SL, Singh N (2012) Pathology of primary and metastatic mucinous ovarian neoplasms. J Clin Pathol 65:591–595PubMedCrossRef Leen SL, Singh N (2012) Pathology of primary and metastatic mucinous ovarian neoplasms. J Clin Pathol 65:591–595PubMedCrossRef
38.
Zurück zum Zitat Carr NJ, Bibeau F, Bradley RF, Dartigues P (2017 Dec) The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei. Histopathology 71(6):847e58. https://doi.org/10.1111/his.13324 CrossRef Carr NJ, Bibeau F, Bradley RF, Dartigues P (2017 Dec) The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei. Histopathology 71(6):847e58. https://​doi.​org/​10.​1111/​his.​13324 CrossRef
39.
Zurück zum Zitat Stewart CJ, Ardakani NM, Doherty DA, Young RH (2014) An evaluation of the morphologic features of low-grade mucinous neoplasms of the appendix metastatic in the ovary and a comparison with primary ovarian mucinous tumors. Int J Gynecol Pathol 33:1–10PubMedCrossRef Stewart CJ, Ardakani NM, Doherty DA, Young RH (2014) An evaluation of the morphologic features of low-grade mucinous neoplasms of the appendix metastatic in the ovary and a comparison with primary ovarian mucinous tumors. Int J Gynecol Pathol 33:1–10PubMedCrossRef
40.
Zurück zum Zitat Nonaka D, Chiriboga L, Soslow RA (2008) Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. Am J Surg Pathol 32:1566–1571PubMedCrossRef Nonaka D, Chiriboga L, Soslow RA (2008) Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. Am J Surg Pathol 32:1566–1571PubMedCrossRef
41.
Zurück zum Zitat Tornos C, Soslow R, Chen S et al (2005) Expression of WT1, CA125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary. Am J Surg Pathol 29:1482–1489PubMedCrossRef Tornos C, Soslow R, Chen S et al (2005) Expression of WT1, CA125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary. Am J Surg Pathol 29:1482–1489PubMedCrossRef
42.
Zurück zum Zitat Liu H, Shi J, Wilkerson ML et al (2012) Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas. Am J Clin Pathol 138:57–64PubMedCrossRef Liu H, Shi J, Wilkerson ML et al (2012) Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas. Am J Clin Pathol 138:57–64PubMedCrossRef
43.
Zurück zum Zitat Bhargava R, Beriwal S, Dabbs DJ (2007) Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity. Am J Clin Pathol 127:103–113PubMedCrossRef Bhargava R, Beriwal S, Dabbs DJ (2007) Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity. Am J Clin Pathol 127:103–113PubMedCrossRef
44.
Zurück zum Zitat Ronnett BM, Yemelyanova AV, Vang R et al (2008) Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumours and the ability of the metastases to simulate primary ovarian neoplasms. Am J Surg Pathol 32:1835–1853PubMedCrossRef Ronnett BM, Yemelyanova AV, Vang R et al (2008) Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumours and the ability of the metastases to simulate primary ovarian neoplasms. Am J Surg Pathol 32:1835–1853PubMedCrossRef
46.
Zurück zum Zitat Le T, Williams K, Senterman M et al (2007) Histopathologic assessment of chemotherapy effects in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking. Gynecol Oncol 106:160–163PubMedCrossRef Le T, Williams K, Senterman M et al (2007) Histopathologic assessment of chemotherapy effects in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking. Gynecol Oncol 106:160–163PubMedCrossRef
47.
Zurück zum Zitat Muraji M, Sudo T, Iwasaki S et al (2013) Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery. Gynecol Oncol 131:531–534PubMedCrossRef Muraji M, Sudo T, Iwasaki S et al (2013) Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery. Gynecol Oncol 131:531–534PubMedCrossRef
50.
Zurück zum Zitat Carr NJ, Sobin LH (2010) Tumours of the appendix. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) WHO Classification of Tumours of the Digestive System, vol 3, 4th edn. IARC Press, Lyon, pp 122–125 Carr NJ, Sobin LH (2010) Tumours of the appendix. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) WHO Classification of Tumours of the Digestive System, vol 3, 4th edn. IARC Press, Lyon, pp 122–125
51.
Zurück zum Zitat Misdraji J, Yantiss RK, Graeme-Cook FM, Balis UJ, Young RH (2003) Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol 27(8):1089–1103PubMedCrossRef Misdraji J, Yantiss RK, Graeme-Cook FM, Balis UJ, Young RH (2003) Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol 27(8):1089–1103PubMedCrossRef
53.
54.
Zurück zum Zitat Bradley RF, Stewart JH, Russell GB, Levine EA, Geisinger KR (2006) Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol 30(5):551–559PubMedCrossRef Bradley RF, Stewart JH, Russell GB, Levine EA, Geisinger KR (2006) Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol 30(5):551–559PubMedCrossRef
55.
Zurück zum Zitat Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) AJCC cancer staging manual, 7th edn. Springer, New York, NY, pp 133–141. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) AJCC cancer staging manual, 7th edn. Springer, New York, NY, pp 133–141.
57.
Zurück zum Zitat Carr NJ, Cecil TD, Mohamed F, Sobin LH, Sugarbaker PH, González-Moreno S, Taflampas P, Chapman S, Moran BJ (2016) A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the peritoneal surface oncology group international (PSOGI) modified Delphi process. Am J Surg Pathol 40(1):14–26. https://doi.org/10.1097/PAS.0000000000000535 CrossRefPubMed Carr NJ, Cecil TD, Mohamed F, Sobin LH, Sugarbaker PH, González-Moreno S, Taflampas P, Chapman S, Moran BJ (2016) A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the peritoneal surface oncology group international (PSOGI) modified Delphi process. Am J Surg Pathol 40(1):14–26. https://​doi.​org/​10.​1097/​PAS.​0000000000000535​ CrossRefPubMed
58.
Zurück zum Zitat Connor SJ, Hanna GB, Frizelle FA (1998) Appendiceal tumors: retrospective clinicopathologic analysis of appendiceal tumors from 7,970 appendectomies. Dis Colon Rectum 41(1):75PubMedCrossRef Connor SJ, Hanna GB, Frizelle FA (1998) Appendiceal tumors: retrospective clinicopathologic analysis of appendiceal tumors from 7,970 appendectomies. Dis Colon Rectum 41(1):75PubMedCrossRef
60.
Zurück zum Zitat Brierley JD, Gospodarowicz MK, Wittekind C (2017) UICC (Union for International Cancer Control) TNM Classification of Malignant Tumours, 8th edn. John Wiley & Sons, Oxford Brierley JD, Gospodarowicz MK, Wittekind C (2017) UICC (Union for International Cancer Control) TNM Classification of Malignant Tumours, 8th edn. John Wiley & Sons, Oxford
61.
Zurück zum Zitat Honoré C, Caruso F, Dartigues P, Benhaim L, Chirica M, Goéré D, Elias D (2015) Strategies for preventing pseudomyxoma peritonei after resection of a mucinous neoplasm of the appendix. Anticancer Res 35(9):4943–4947PubMed Honoré C, Caruso F, Dartigues P, Benhaim L, Chirica M, Goéré D, Elias D (2015) Strategies for preventing pseudomyxoma peritonei after resection of a mucinous neoplasm of the appendix. Anticancer Res 35(9):4943–4947PubMed
63.
Zurück zum Zitat Guaglio M, Sinukumar S, Kusamura S, Milione M, Pietrantonio F, Battaglia L, Guadagni S, Baratti D, Deraco M (2018) Clinical surveillance after macroscopically complete surgery for low-grade appendiceal mucinous neoplasms (LAMN) with or without limited peritoneal spread: long-term results in a prospective series. Ann Surg Oncol 25(4):878–884. https://doi.org/10.1245/s10434-017-6305-5 CrossRefPubMed Guaglio M, Sinukumar S, Kusamura S, Milione M, Pietrantonio F, Battaglia L, Guadagni S, Baratti D, Deraco M (2018) Clinical surveillance after macroscopically complete surgery for low-grade appendiceal mucinous neoplasms (LAMN) with or without limited peritoneal spread: long-term results in a prospective series. Ann Surg Oncol 25(4):878–884. https://​doi.​org/​10.​1245/​s10434-017-6305-5 CrossRefPubMed
65.
Zurück zum Zitat Misdraji J, Lauwers GY, Irving JA, Batts KP, Young RH (2014) Appendiceal or cecal endometriosis with intestinal metaplasia: a potential mimic of appendiceal mucinous neoplasms. Am J Surg Pathol 38:698–705PubMedCrossRef Misdraji J, Lauwers GY, Irving JA, Batts KP, Young RH (2014) Appendiceal or cecal endometriosis with intestinal metaplasia: a potential mimic of appendiceal mucinous neoplasms. Am J Surg Pathol 38:698–705PubMedCrossRef
66.
Zurück zum Zitat Mitchell A, Dube P, Sideris L (2014) Dysplastic intestinal-type metaplasia of appendiceal endometriosis: a mimic of low grade appendiceal mucinous neoplasm. Diagn Pathol 9:39PubMedPubMedCentralCrossRef Mitchell A, Dube P, Sideris L (2014) Dysplastic intestinal-type metaplasia of appendiceal endometriosis: a mimic of low grade appendiceal mucinous neoplasm. Diagn Pathol 9:39PubMedPubMedCentralCrossRef
67.
Zurück zum Zitat Sirintrapun SJ, Blackham AU, Russell G et al (2014) Significance of signet ring cells in high-grade mucinous adenocarcinoma of the peritoneum from appendiceal origin. Hum Pathol 45:1597–1604PubMedPubMedCentralCrossRef Sirintrapun SJ, Blackham AU, Russell G et al (2014) Significance of signet ring cells in high-grade mucinous adenocarcinoma of the peritoneum from appendiceal origin. Hum Pathol 45:1597–1604PubMedPubMedCentralCrossRef
68.
Zurück zum Zitat Davison JM, Choudry HA, Pingpank JF et al (2014) Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade. Mod Pathol 27:1521–1539PubMedCrossRef Davison JM, Choudry HA, Pingpank JF et al (2014) Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade. Mod Pathol 27:1521–1539PubMedCrossRef
69.
Zurück zum Zitat Shetty S, Natarajan B, Thomas P, Govindarajan V, Sharma P, Loggie B (2013) Proposed classification of pseudomyxoma peritonei: influence of signet ring cells on survival. Am Surg 79:1171–1176PubMed Shetty S, Natarajan B, Thomas P, Govindarajan V, Sharma P, Loggie B (2013) Proposed classification of pseudomyxoma peritonei: influence of signet ring cells on survival. Am Surg 79:1171–1176PubMed
70.
Zurück zum Zitat Taggart MW, Galbincea J, Mansfield PF et al (2013) High-level microsatellite instability in appendiceal carcinomas. Am J Surg Pathol 37:1192–1200PubMedPubMedCentralCrossRef Taggart MW, Galbincea J, Mansfield PF et al (2013) High-level microsatellite instability in appendiceal carcinomas. Am J Surg Pathol 37:1192–1200PubMedPubMedCentralCrossRef
71.
72.
Zurück zum Zitat Baratti D, Kusamura S, Milione M, Bruno F, Guaglio M, Deraco M (2018) Validation of the recent PSOGI pathological classification of pseudomyxoma peritonei—a single center series of 265 patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 25(2):404–413. https://doi.org/10.1245/s10434-017-6252-1 CrossRefPubMed Baratti D, Kusamura S, Milione M, Bruno F, Guaglio M, Deraco M (2018) Validation of the recent PSOGI pathological classification of pseudomyxoma peritonei—a single center series of 265 patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 25(2):404–413. https://​doi.​org/​10.​1245/​s10434-017-6252-1 CrossRefPubMed
73.
Zurück zum Zitat Choudry HA, Pai RK, Shuai Y, Ramalingam L, Jones HL, Pingpank JF, Ahrendt SS, Holtzman MP, Zureikat AH, Zeh HJ, Bartlett DL (2018) Impact of cellularity on oncologic outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for pseudomyxoma peritonei. Ann Surg Oncol 25(1):76–82. https://doi.org/10.1245/s10434-017-6214-7 CrossRefPubMed Choudry HA, Pai RK, Shuai Y, Ramalingam L, Jones HL, Pingpank JF, Ahrendt SS, Holtzman MP, Zureikat AH, Zeh HJ, Bartlett DL (2018) Impact of cellularity on oncologic outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for pseudomyxoma peritonei. Ann Surg Oncol 25(1):76–82. https://​doi.​org/​10.​1245/​s10434-017-6214-7 CrossRefPubMed
74.
Zurück zum Zitat Mohamed F, Gething S, Haiba M, Brun EA, Sugarbaker PH et al (2004) Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process. J Surg Oncol 86(1):10e5CrossRef Mohamed F, Gething S, Haiba M, Brun EA, Sugarbaker PH et al (2004) Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process. J Surg Oncol 86(1):10e5CrossRef
75.
Zurück zum Zitat Vang R, Gown AM, Zhao C et al (2007) Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary. Am J Surg Pathol 31:854–869PubMedCrossRef Vang R, Gown AM, Zhao C et al (2007) Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary. Am J Surg Pathol 31:854–869PubMedCrossRef
76.
Zurück zum Zitat Choi YJ, Lee SH, Kim MS et al (2016) Whole-exome sequencing identified the genetic origin of a mucinous neoplasm in a mature cystic teratoma. Pathology 48:372–376PubMedCrossRef Choi YJ, Lee SH, Kim MS et al (2016) Whole-exome sequencing identified the genetic origin of a mucinous neoplasm in a mature cystic teratoma. Pathology 48:372–376PubMedCrossRef
77.
Zurück zum Zitat McKenney JK, Soslow RA, Longacre TA (2008) Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei. Am J Surg Pathol 32:645–655PubMedCrossRef McKenney JK, Soslow RA, Longacre TA (2008) Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei. Am J Surg Pathol 32:645–655PubMedCrossRef
78.
Zurück zum Zitat Lee KR, Scully RE (2000) Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'. Am J Surg Pathol 24:1447–1464PubMedCrossRef Lee KR, Scully RE (2000) Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'. Am J Surg Pathol 24:1447–1464PubMedCrossRef
79.
Zurück zum Zitat Sheldon CA, Clayman RV, Gonzalez R, Williams RD, Fraley EE (1984) Malignant urachal lesions. J Urol 131:1–8PubMedCrossRef Sheldon CA, Clayman RV, Gonzalez R, Williams RD, Fraley EE (1984) Malignant urachal lesions. J Urol 131:1–8PubMedCrossRef
80.
Zurück zum Zitat Cappele O, Sibert L, Descargues J, Delmas V, Grise P (2001) A study of the anatomic features of the duct of the urachus. Surg Radiol Anat 23:229–235PubMedCrossRef Cappele O, Sibert L, Descargues J, Delmas V, Grise P (2001) A study of the anatomic features of the duct of the urachus. Surg Radiol Anat 23:229–235PubMedCrossRef
81.
82.
Zurück zum Zitat de Bree E, Witkamp A, Van de Vijver M, Zoetmulder F (2000) Unusual origins of pseudomyxoma peritonei. J Surg Oncol 75:270–274PubMedCrossRef de Bree E, Witkamp A, Van de Vijver M, Zoetmulder F (2000) Unusual origins of pseudomyxoma peritonei. J Surg Oncol 75:270–274PubMedCrossRef
83.
Zurück zum Zitat Loggie BW, Fleming RA, Hosseinian AA (1997) Peritoneal carcinomatosis with urachal signet-cell adenocarcinoma. Urology 50:446–448PubMedCrossRef Loggie BW, Fleming RA, Hosseinian AA (1997) Peritoneal carcinomatosis with urachal signet-cell adenocarcinoma. Urology 50:446–448PubMedCrossRef
84.
Zurück zum Zitat Santucci RA, True LD, Lange PH (1997) Is partial cystectomy the treatment of choice for mucinous adenocarcinoma of the urachus. Urology 49:536–540PubMedCrossRef Santucci RA, True LD, Lange PH (1997) Is partial cystectomy the treatment of choice for mucinous adenocarcinoma of the urachus. Urology 49:536–540PubMedCrossRef
85.
Zurück zum Zitat Sugarbaker PH, Verghese M, Yan TD, Brun E (2008) Management of mucinous urachal neoplasm presenting as pseudomyxoma peritonei. Tumori 94(5):732–736PubMedCrossRef Sugarbaker PH, Verghese M, Yan TD, Brun E (2008) Management of mucinous urachal neoplasm presenting as pseudomyxoma peritonei. Tumori 94(5):732–736PubMedCrossRef
86.
Zurück zum Zitat Husain AN, Colby TV, Ordóñez NG, Allen TC, Attanoos RL, Beasley MB, Butnor KJ, Chirieac LR, Churg AM, Dacic S, Galateau-Sallé F, Gibbs A, Gown AM, Krausz T, Litzky LA, Marchevsky A, Nicholson AG, Roggli VL, Sharma AK, Travis WD, Walts AE, Wick MR (2018) Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 142(1):89–108. https://doi.org/10.5858/arpa.2017-0124-RA CrossRefPubMed Husain AN, Colby TV, Ordóñez NG, Allen TC, Attanoos RL, Beasley MB, Butnor KJ, Chirieac LR, Churg AM, Dacic S, Galateau-Sallé F, Gibbs A, Gown AM, Krausz T, Litzky LA, Marchevsky A, Nicholson AG, Roggli VL, Sharma AK, Travis WD, Walts AE, Wick MR (2018) Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 142(1):89–108. https://​doi.​org/​10.​5858/​arpa.​2017-0124-RA CrossRefPubMed
87.
Zurück zum Zitat Goldblum J, Hart WR (1995) Localized and diffuse mesotheliomas of the genital tract and peritoneum in women: a clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas, and localized fibrous tumors. Am J Surg Pathol 19(10):1124–1137PubMedCrossRef Goldblum J, Hart WR (1995) Localized and diffuse mesotheliomas of the genital tract and peritoneum in women: a clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas, and localized fibrous tumors. Am J Surg Pathol 19(10):1124–1137PubMedCrossRef
88.
Zurück zum Zitat Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG (eds) (2015) WHO. Classification of tumours of the lung, pleura, thymus and heart, vol 7, 4th edn. IARC Press, Lyon Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG (eds) (2015) WHO. Classification of tumours of the lung, pleura, thymus and heart, vol 7, 4th edn. IARC Press, Lyon
89.
Zurück zum Zitat Churg A, Allen T, Borczuk AC et al (2014) Well-differentiated papillary mesothelioma with invasive foci. Am J Surg Pathol 38(7):990–998PubMedCrossRef Churg A, Allen T, Borczuk AC et al (2014) Well-differentiated papillary mesothelioma with invasive foci. Am J Surg Pathol 38(7):990–998PubMedCrossRef
90.
Zurück zum Zitat Churg A, Cagle PT, Roggli VL (eds) (2006) Tumors of the serosal membranes. Armed Registry of Pathology, and Washington, DC: Armed Forces Institute of Pathology, Silver Spring Atlas of Tumor Pathology; 4th series, fascicle Churg A, Cagle PT, Roggli VL (eds) (2006) Tumors of the serosal membranes. Armed Registry of Pathology, and Washington, DC: Armed Forces Institute of Pathology, Silver Spring Atlas of Tumor Pathology; 4th series, fascicle
91.
Zurück zum Zitat Kadota K, Suzuki K, Sima CS, Rusch VW, Adusumilli PS, Travis WD (2011) Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma. J Thorac Oncol 6(5):896–904PubMedCrossRef Kadota K, Suzuki K, Sima CS, Rusch VW, Adusumilli PS, Travis WD (2011) Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma. J Thorac Oncol 6(5):896–904PubMedCrossRef
92.
93.
Zurück zum Zitat Ordonez NG (2012) Deciduoid mesothelioma: report of 21 cases with review of the literature. Mod Pathol 25(11):1481–1495PubMedCrossRef Ordonez NG (2012) Deciduoid mesothelioma: report of 21 cases with review of the literature. Mod Pathol 25(11):1481–1495PubMedCrossRef
94.
Zurück zum Zitat Kawai T, Hiroi S, Nakanishi K et al (2010) Lymphohistiocytoid mesothelioma of the pleura. Pathol Int 60(8):566–574PubMedCrossRef Kawai T, Hiroi S, Nakanishi K et al (2010) Lymphohistiocytoid mesothelioma of the pleura. Pathol Int 60(8):566–574PubMedCrossRef
95.
Zurück zum Zitat Travis WD (2010) Sarcomatoid neoplasms of the lung and pleura. Arch Pathol Lab Med 134(11):1645–1658PubMed Travis WD (2010) Sarcomatoid neoplasms of the lung and pleura. Arch Pathol Lab Med 134(11):1645–1658PubMed
96.
Zurück zum Zitat Kiyozuka Y, Miyazaki H, Yoshizawa K et al (1999) An autopsy case of malignant mesothelioma with osseous and cartilaginous differentiation: bone morphogenetic protein-2 in mesothelial cells and its tumor. Dig Dis Sci 44(8):1626PubMedCrossRef Kiyozuka Y, Miyazaki H, Yoshizawa K et al (1999) An autopsy case of malignant mesothelioma with osseous and cartilaginous differentiation: bone morphogenetic protein-2 in mesothelial cells and its tumor. Dig Dis Sci 44(8):1626PubMedCrossRef
97.
Zurück zum Zitat Suen HC, Sudholt B, Anderson WM, Lakho MH, Daily BB (2002) Malignant mesothelioma with osseous differentiation. Ann Thorac Surg 73(2):665PubMedCrossRef Suen HC, Sudholt B, Anderson WM, Lakho MH, Daily BB (2002) Malignant mesothelioma with osseous differentiation. Ann Thorac Surg 73(2):665PubMedCrossRef
98.
Zurück zum Zitat Yousem SA, Hochholzer L (1987) Malignant mesotheliomas with osseous and cartilaginous differentiation. Arch Pathol Lab Med 111(1):62–66PubMed Yousem SA, Hochholzer L (1987) Malignant mesotheliomas with osseous and cartilaginous differentiation. Arch Pathol Lab Med 111(1):62–66PubMed
99.
Zurück zum Zitat Borczuk AC, Taub RN, Hesdorffer M et al (2005) p16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma. Clin Cancer Res 11(9):3303–3308PubMedCrossRef Borczuk AC, Taub RN, Hesdorffer M et al (2005) p16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma. Clin Cancer Res 11(9):3303–3308PubMedCrossRef
100.
101.
Zurück zum Zitat Comin CE, Saieva C, Messerini L (2007) h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary. Am J Surg Pathol 31(8):1139–1148PubMedCrossRef Comin CE, Saieva C, Messerini L (2007) h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary. Am J Surg Pathol 31(8):1139–1148PubMedCrossRef
102.
Zurück zum Zitat Ordonez NG (2013) Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas. Mod Pathol 26(4):553–562PubMedCrossRef Ordonez NG (2013) Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas. Mod Pathol 26(4):553–562PubMedCrossRef
103.
Zurück zum Zitat Comin CE, Saieva C, Messerini L (2007) h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary. Am J Surg Pathol 31(8):1139–1148PubMedCrossRef Comin CE, Saieva C, Messerini L (2007) h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary. Am J Surg Pathol 31(8):1139–1148PubMedCrossRef
104.
Zurück zum Zitat Ordonez NG (2006) Value of immunohistochemistry in distinguishing peritoneal mesothelioma from serous carcinoma of the ovary and peritoneum: a review and update. Adv Anat Pathol 13(1):16–25PubMedCrossRef Ordonez NG (2006) Value of immunohistochemistry in distinguishing peritoneal mesothelioma from serous carcinoma of the ovary and peritoneum: a review and update. Adv Anat Pathol 13(1):16–25PubMedCrossRef
105.
Zurück zum Zitat Barnetson RJ, Burnett RA, Downie I, Harper CM, Roberts F (2006) Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful. Am J Clin Pathol 125(1):67–76PubMedCrossRef Barnetson RJ, Burnett RA, Downie I, Harper CM, Roberts F (2006) Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful. Am J Clin Pathol 125(1):67–76PubMedCrossRef
106.
Zurück zum Zitat Takeshima Y, Amatya VJ, Kushitani K, Inai K (2008) A useful antibody panel for differential diagnosis between peritoneal mesothelioma and ovarian serous carcinoma in Japanese cases. Am J Clin Pathol 130(5):771–779PubMedCrossRef Takeshima Y, Amatya VJ, Kushitani K, Inai K (2008) A useful antibody panel for differential diagnosis between peritoneal mesothelioma and ovarian serous carcinoma in Japanese cases. Am J Clin Pathol 130(5):771–779PubMedCrossRef
108.
Zurück zum Zitat Kusamura S, Torres Mesa PA, Cabras A et al (2016) The role of Ki-67 and pre-cytoreduction parameters in selecting diffuse malignant peritoneal mesothelioma (DMPM) patients for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 23:1468–1473PubMedCrossRef Kusamura S, Torres Mesa PA, Cabras A et al (2016) The role of Ki-67 and pre-cytoreduction parameters in selecting diffuse malignant peritoneal mesothelioma (DMPM) patients for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 23:1468–1473PubMedCrossRef
109.
Zurück zum Zitat Yan TD, Deraco M, Elias D, Glehen O, Levine EA, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH (2011) Peritoneal surface oncology group. A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database. Cancer 117(9):1855–1863PubMedCrossRef Yan TD, Deraco M, Elias D, Glehen O, Levine EA, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH (2011) Peritoneal surface oncology group. A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database. Cancer 117(9):1855–1863PubMedCrossRef
110.
Zurück zum Zitat Cook DS, Attanoos RL, Jalloh SS, Gibbs AR (2000) 'Mucin-positive' epithelial mesothelioma of the peritoneum: an unusual diagnostic pitfall. Histopathology 37:33–36PubMedCrossRef Cook DS, Attanoos RL, Jalloh SS, Gibbs AR (2000) 'Mucin-positive' epithelial mesothelioma of the peritoneum: an unusual diagnostic pitfall. Histopathology 37:33–36PubMedCrossRef
111.
Zurück zum Zitat Facchetti F, Lonardi S, Gentili F et al (2007) Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions. Virchows Arch 451:669–680PubMedCrossRef Facchetti F, Lonardi S, Gentili F et al (2007) Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions. Virchows Arch 451:669–680PubMedCrossRef
112.
Zurück zum Zitat Angarita FA, Hassan S, Cannell AJ, Dickson BC, Gladdy RA, Swallow CJ, Gupta A, Blackstein ME, McCart JA (2017) Clinical features and outcomes of 20 patients with abdominopelvic desmoplastic small round cell tumor. Eur J Surg Oncol 43(2):423–431PubMedCrossRef Angarita FA, Hassan S, Cannell AJ, Dickson BC, Gladdy RA, Swallow CJ, Gupta A, Blackstein ME, McCart JA (2017) Clinical features and outcomes of 20 patients with abdominopelvic desmoplastic small round cell tumor. Eur J Surg Oncol 43(2):423–431PubMedCrossRef
113.
Zurück zum Zitat Chan AS, MacNeill S, Thorner P, Squire J, Zielenska M (1999) Variant EWS-WT1 chimeric product in the desmoplastic small round cell tumor. Pediatr Dev Pathol 2:188–192PubMedCrossRef Chan AS, MacNeill S, Thorner P, Squire J, Zielenska M (1999) Variant EWS-WT1 chimeric product in the desmoplastic small round cell tumor. Pediatr Dev Pathol 2:188–192PubMedCrossRef
114.
Zurück zum Zitat Rodriguez E, Sreekantaiah C, Gerald W, Reuter VE, Motzer RJ, Chaganti RS (1993) A recurring translocation, t(11;22)(p13;q11.2), characterizes intra-abdominal desmoplastic small round-cell tumors. Cancer Genet Cytogenet 69:17–21PubMedCrossRef Rodriguez E, Sreekantaiah C, Gerald W, Reuter VE, Motzer RJ, Chaganti RS (1993) A recurring translocation, t(11;22)(p13;q11.2), characterizes intra-abdominal desmoplastic small round-cell tumors. Cancer Genet Cytogenet 69:17–21PubMedCrossRef
115.
Zurück zum Zitat Ladanyi M, Gerald W (1994) Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res 54:2837–2840PubMed Ladanyi M, Gerald W (1994) Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res 54:2837–2840PubMed
116.
Zurück zum Zitat Taubert H, Wissner S, Haskins A (1965) Leiomyomatosis peritonealis disseminata: an unusual complication of genital leiomyomata. Obstet Gynecol 25:561–574PubMed Taubert H, Wissner S, Haskins A (1965) Leiomyomatosis peritonealis disseminata: an unusual complication of genital leiomyomata. Obstet Gynecol 25:561–574PubMed
117.
Zurück zum Zitat Churg A, Cagle PT, Roggli VL (2006) Tumors of the serosal membranes. ARP, Silver Spring Churg A, Cagle PT, Roggli VL (2006) Tumors of the serosal membranes. ARP, Silver Spring
118.
Zurück zum Zitat Mueller F, Kuehn K, Neudeck H, Nina S, Uwe U et al (2012) Disseminated peritoneal leiomyomatosis with endometriosis. J Minim Invasive Gynecol 19(3):380–382PubMedCrossRef Mueller F, Kuehn K, Neudeck H, Nina S, Uwe U et al (2012) Disseminated peritoneal leiomyomatosis with endometriosis. J Minim Invasive Gynecol 19(3):380–382PubMedCrossRef
Metadaten
Titel
Essentials for Pathological Evaluation of Peritoneal Surface Malignancies and Synoptic Reporting of Cytoreductive Surgery Specimens—A review and evidence-based guide
verfasst von
Aditi Bhatt
Suniti Mishra
Loma Parikh
Sandeep Sheth
Imran Gorur
Publikationsdatum
19.03.2019
Verlag
Springer India
Erschienen in
Indian Journal of Surgical Oncology / Ausgabe 1/2020
Print ISSN: 0975-7651
Elektronische ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-019-00897-7

Neu im Fachgebiet Chirurgie

Ab sofort gelten die neuen Verordnungsausnahmen für Lipidsenker

Freie Fahrt für Lipidsenker? Das nicht, doch mit niedrigerem Schwellenwert fürs Infarktrisiko und neuen Indikationen hat der G-BA die Verordnungs-Handbremse ein gutes Stück weit gelockert.

Appendizitis und Darminfarkt durch Blinddarm-Lipom

Eigentlich sind Lipome recht harmlos. Im Zäkum können sie jedoch erhebliche Komplikationen mit Darminfarkt und Appendizitis verursachen.

Gluteuslappen nach Rektumkarzinom-Op. schützt vor Abszessen

Die Wunddeckung mit einem autologen Rotationslappen nach Entfernung eines Rektumkarzinoms konnte in einer randomisierten Studie gegenüber dem primären Wundverschluss vor allem in einer Hinsicht punkten: Sie führte deutlich seltener zu präsakralen Abszessen.

MedTalk Leitlinie KOMPAKT: S3-Leitline zu peripheren Nervenverletzungen

  • Webinar | 10.02.2025 | 13:00

Über den Weg zur finalen Fassung der S3-Leitlinie "Versorgung peripherer Nervenverletzungen" sprechen Prof. Dr. Leila Harhaus-Wähner und Ressortleiter Dr. Gunter Freese im WebTalk Leitlinie KOMPAKT, einer neuen Webcast-Serie von SpringerMedizin passend zu Ihrem Fachmagazin Orthopädie und Unfallchirurgie Mitteilungen und Nachrichten. In dem kurzen Video geht es darum, was sich im Vergleich zur vorigen Fassung der Leitlinie geändert hat, welche Aspekte für die tägliche Praxis besonders wichtig sind und was jeder gemäß Leitlinie nun anders oder besser machen sollte.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.